Učitavanje...
Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
Undoubtedly, the new SARS‐CoV‐2 virus poses a grave health threat, plaguing the health and socio‐economic sectors. COVID‐19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying...
Spremljeno u:
| Izdano u: | J Cell Mol Med |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675715/ https://ncbi.nlm.nih.gov/pubmed/33009727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15941 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|